Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ingrid Courtney
Observed names:
I. Courtney,
I.J. Courtney
Institution:
Stellenbosch University
Observed institutions:
Desmond Tutu HIV Foundation,
University of Cape Town,
Stellenbosch University,
Institute of Infectious Disease and Molecular Medicine
ORCID:
0009-0004-1035-3202
Observed ORCID:
0009-0004-1035-3202
OpenAlex ID:
A5019352676
Internalized HIV stigma, ART initiation and HIV ‐1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator
2018
·
Valerie A Earnshaw
, Laura M Bogart
, et al.
·
Journal of the International AIDS Society
·
85
PDF
Exploring Treatment Needs and Expectations for People Living with HIV in South Africa: A Qualitative Study
2018
·
Valerie A. Earnshaw
, Laura M. Bogart
, et al.
·
AIDS and Behavior
·
30
Trajectories of HIV-related internalized stigma and disclosure concerns among art initiators and noninitiators in South Africa.
2019
·
Brian T. Chan
, Brendan G. Maughan-Brown
, et al.
·
Stigma and Health
·
24
Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study
2019
·
Ingrid T. Katz
, Laura M. Bogart
, et al.
·
AIDS
·
23
The Treatment Ambassador Program: A Highly Acceptable and Feasible Community-Based Peer Intervention for South Africans Living with HIV Who Delay or Discontinue Antiretroviral Therapy
2020
·
Ingrid T. Katz
, Laura M. Bogart
, et al.
·
AIDS and Behavior
·
21
PDF
Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis
2025
·
Jennifer A Hughes
, Belén P Solans
, et al.
·
The Journal of Infectious Diseases
·
14
Recreational ART use among individuals living with HIV/AIDS in South Africa: Examining longitudinal ART initiation and viral suppression
2019
·
Jessica F. Magidson
, Hari S. Iyer
, et al.
·
Drug and Alcohol Dependence
·
10
PDF
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
2025
·
Megan Palmer
, Yuanxi Zou
, et al.
·
British Journal of Clinical Pharmacology
·
6
PDF
Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines
2021
·
Maria F. Nardell
, Bethany Hedt-Gauthier
, et al.
·
AIDS and Behavior
·
5
Lung function trajectories in children with pulmonary TB and non-TB lower respiratory tract infections
2025
·
I.J. Courtney
, M. Palmer
, et al.
·
IJTLD OPEN
·
4
Acceptability of clofazimine capsules in children and adolescents with rifampicin-resistant TB
2024
·
D.T. Wademan
, Z. Saule
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
3
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis
2026
·
Elri Nortier
, Milena M Boczar
, et al.
·
The Journal of Infectious Diseases
·
1
Trials, tribulations, and formulations in access to new TB drugs for children: learning from rifapentine
2026
·
A.C. Hesseling
, N. Salazar-Austin
, et al.
·
IJTLD OPEN
Pharmacokinetics of Clofazimine Tablet Formulation in Children with Rifampicin-Resistant Tuberculosis in CATALYST, a Multi-Site International Trial
2026
·
Yuanxi Zou
, Megan Palmer
, et al.
·
Journal of the Pediatric Infectious Diseases Society
PDF
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)
2026
·
Ingrid Courtney
, Meredith G Dixon
, et al.
·
JMIR Research Protocols
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention
2026
·
Ruvarashe J. Madzime
, Louvina van der Laan
, et al.
·
Microbiology Spectrum
Show more works
View as search
Works count:
16
Citation count:
226
H-index:
7
I10-index:
7
Year
Topic
Type